Scholarly Index
Kanokvalai Kulthanan
Siriraj Hospital; 7,260 total citations; 198 total publications; best world rank #63
Siriraj Hospital
7,260Total citations
198Total publications
39H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Urticaria and Related Conditions | Lifetime | 234 | TH 1 | 97.82 |
| Autoimmune Bullous Skin Diseases | Lifetime | 279 | TH 1 | 97.92 |
| Dermatology and Skin Diseases | Lifetime | 597 | TH 1 | 97.25 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 475 | TH 1 | 96.45 |
| Drug-Induced Adverse Reactions | Lifetime | 455 | TH 4 | 94.50 |
| Mast cells and histamine | Lifetime | 939 | TH 2 | 92.80 |
| Acne and Rosacea Treatments and Effects | Lifetime | 595 | TH 5 | 89.51 |
| Urticaria and Related Conditions | 2021-2025 | 63 | TH 1 | 97.08 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 132 | TH 1 | 93.32 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 200 | TH 3 | 93.28 |
| Dermatology and Skin Diseases | 2021-2025 | 528 | TH 1 | 92.47 |
| Mast cells and histamine | 2021-2025 | 125 | TH 1 | 91.22 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 949 | TH 7 | 86.25 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 662 | TH 19 | 64.43 |
| Dermatological and COVID-19 studies | 2021-2025 | 705 | TH 3 | 52.56 |